the Management of Weight Regain After Gastric Bypass by Endoscopic SuturingAPOLLONCT02048033
Assessment of the Overstich Technique for the Management of Weight Regain After Gastric Bypass.
A study testing Regular endoscopy + endogastric suturing and Regular endoscopy in people with the Management of Weight Regain After Gastric Bypass by Endoscopic Suturing, run by University Hospital, Montpellier at 7 sites in France.
Trial summary
Prospective multicenters randomized study to compare the efficiency and the socioeconomic impact of the endoscopic management (Overstitch technique) of weight regain after gastric bypass surgery to non invasive treatment Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- the Management of Weight Regain After Gastric Bypass by Endoscopic Suturing
- What is being tested?
- Regular endoscopy + endogastric suturing and Regular endoscopy
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 74 participants
- Where
- 7 sitesFrance
- Study dates
- 3 Jan 2014to 11 Apr 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age > 18 years
- Surgical criteria: patient with bariatric surgery by gastric bypass since, at least, 24 months
- Clinics criteria of weight regain or treatment failure:
- Patient with weight regain> 5kg / m²
- Patient with EWL (excess weight loss) <25% after 2 years of treatment.
- Loss of early satiety (interrogation)
Show all 10Show fewer
- Patient with a compatible psychological and cognitive status with the study,
- Patient agreeing to follow the procedures of the study and can participate at the follow-up study during 2 years
- Subject with no rights from the national health insurance programme
- Consent form signed
Who cannot join
- Pregnancy (plasma assay of beta-HCG positive)
- Presence of cardiovascular, neurological, psychiatric, endocrine, renal, gastrointestinal or tumor comorbidities making irrelevant patient participation in the judgment of the investigator
- Patient participating in another clinical study or participated in another study within the last 30 days or for which the annual compensation received exceeds € 4,500
- Patient with a contre-indication to the achievement of surgery (fistula, ulceration, ...)
Trial locations and contacts
7 sites in 1 country.
7 sites in 1 country
France7 sites
Louis Mourier Hospital
Colombes, 92700
Lille Hospital
Lille
Montpellier Hospital
Montpellier, 34000
Nice Hospital
Nice, 06000
HEGP Hospital
Paris, 75015
Strasbourg Hospital
Strasbourg, 67000
Villeurbanne clinic
Villeurbanne, 69000
About this study
Official title: Medico-economic Evaluation of the Management of Weight Regain After Gastric Bypass by Gastrointestinal Narrowing of Jejunal Anastomosis by Endoscopic Suturing: Apollo Endosurgery OverStitch Technical
Prospective multicenters randomized study to compare the efficiency and the socioeconomic impact of the endoscopic management (Overstitch technique) of weight regain after gastric bypass surgery to non invasive treatment
Read the detailed description
Nowadays morbid obesity (BMI ≥ 40kg/m²) is a major problem of public health in industrialized countries. About 500 000 patients would be affected by this disease in France in 2009. Prevalence of the morbid obesity raised from 0.3 % (± 0.1 %) of the population in 1997 to 1.1 % (± 0.1 %) in 2009 (Extrapolation of the data ObEpi on 2009 to the French population) (1). For this type of patient, the only long-term effective treatment recognized by the scientists is the bariatric surgery. (2-4) Roux and Y Gastric Bypass (GBP) is a consensual procedure, that has been described in the sixties, in this indication (approximately 11000 GBP performed in FRance in 2012 (5,6). This operation consists on the creation of a proximal gastric pouch (50 cc). A Roux and Y intestinal loop will be added to create a malabsorptive part. 60 to 80 % of excess weight loss described in the literature in the long-terms. Furthermore, improvement or remission of T2DM, sleep apnea syndrome, arterial hyperpressure, dyslipidemia) are emphasized in many trials (5, 7). However 15 to 20 % of the handled patients present a weight regain 5 years post surgery potentially explained by the dilation of the gastric pouch or the gastro jejunal anastomosis and thus a decrease of the restrictive effect. (8-11) To palliate this complication two solutions are described. (12-15; 19) The first one consists in a recalibration of the gastric poouch by surgical approachy. In this case, a ring of silicone or polypropylene can be positioned around the gastric pocket. Other possible solution is to redo a new gastrojejunostomy with a smaller size, by surgical access (laparotomy or laparoscopy). These interventions are very delicate because of important peritoneal adhesions and present a rate of significant morbidity especially if they are performed under laparotomy. The pure medical care does not allow long-term results stable. ²² A therapeutic dead end is reported often for this type of patient. A new possibility was recently described. (17-18) A recalibration can be realized by sutures performed under endoscopic approach at the level of the gastro jejunal anastomosis or from the gastric pouch by the APOLLO Endosurgery OverStitch. The digestive surgery by endoscopic way is rapidly expanding. The first results seem to be promising (resumed the weight loss) but owe to be estimated in a randomized study comparing this new process with the medical conventional treatment. A single-blind, randomized, forward-looking study, multicenter, comparative between two parallel groups of patients presenting a weight regain after GBP was thus organized. The main objective is to estimate the efficiency of the APOLLO Endosurgery OverStitch technique versus the non-interventional strategy. The secondary endpoints is to study the morbidity of the procedure, the evolution of quality of life of the patients, the medical economic impact of the innovation in 24 months.
- Being tested
- Regular endoscopy + endogastric suturing, Regular endoscopy
- Keywords
- Obesity, Endogastric suturing, Jujenal anastomosis, weight regain
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Regular endoscopy + endogastric suturingDevice
Patients will get the usual endoscopy used for diagnosis. In addition, they will receive an endoscopic surgery using the APOLLO Endosuregery technique. The Apollo Endosurgery OverStitch is an endoscopic equipment which involves the suturing by endogastric way to decrease the size of the anastomosis gastrojujenal or gastric pouch
Regular endoscopyDiagnostic test
Patients will get the usual endoscopy used for diagnosis.
| Study group | Role | What they receive |
|---|---|---|
| Arm with Apollo Endosurgery OverStitch technical | Active comparator | Not described Receives: Device: Regular endoscopy + endogastric suturing |
| Arm without Apollo Endosurgery OverStitch technical | Placebo comparator | Not described Receives: Diagnostic Test: Regular endoscopy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight loss assessment of Apollo Endosurgery OverStitch technical
The main objective is to compare the efficacy of endoscopic surgery Apollo Endosurgery OverStitch technical than the conventional non-interventional strategy in patients with weight regain after gastric bypass.Moreover, all of these patients will also benefit from the medical-nutritional usual care.
Measured: At 12 and 24 months after surgery
Secondary outcomes (4)
Comparison of both strategies on tolerance (adverse events and serious adverse events)
The secondary objectives of this study were to compare in real life these both strategies of the management of weight regain after gastric bypass on tolerance and safety related to obesity.
Measured: At 12 months after Baseline and at each visit
Comparison of both strategies on comorbidities
The secondary objectives of this study were to compare in real life these both strategies of the management of weight regain after gastric bypass on comorbidities related to obesity (type 2 diabetes, arterial hypertension, sleep apnea syndrome, ...).
Measured: At 12 months after Baseline and at each visit
Comparison of both strategies on quality of life
The secondary objectives of this study were to compare in real life these both strategies of the management of weight regain after gastric bypass on quality of life.
Measured: At 12 months after Baseline and at each visit
Comparison of both strategies on medico-economic impact (drugs fees, medical consultation fees..)
The secondary objectives of this study were to compare in real life these both strategies of the management of weight regain after gastric bypass on medico-economic impact of innovation.
Moreover, a cost-effectiveness analysis will be performed at the end of this study.
Measured: At 12 months after Baseline and at each visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2014 (estimated)
- Study start3 Jan 2014
- Primary completionDec 2016
- Study completion11 Apr 2017
Why it stopped: Following the occurrence of four serious adverse events in the APOLLO group and after discussion with the investigator, we consider that this minimally invasive protocol causes an increased risk of morbidity and mortality.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for the Management of Weight Regain After Gastric Bypass by Endoscopic SuturingStudies of the same condition, open and under way.
- More trials run by University Hospital, MontpellierThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 74 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Montpellier
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02048033
- Sponsor's protocol ID
- 50372
- Acronym
- APOLLO
- Status last verified
- Sep 2025
- First submitted
- 16 Jan 2014
- Last updated
- 3 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Medico-economic Evaluation of the Management of Weight Regain After Gastric Bypass by Gastrointestinal Narrowing of Jejunal Anastomosis by Endoscopic Suturing: Apollo Endosurgery OverStitch Technical
- ClinicalTrials.gov ID
- NCT02048033
- Acronym / sponsor ID
- APOLLO / 50372
- Keywords
- Obesity, Endogastric suturing, Jujenal anastomosis, weight regain
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Following the occurrence of four serious adverse events in the APOLLO group and after discussion with the investigator, we consider that this minimally invasive protocol causes an increased risk of morbidity and mortality.
- Enrolment
- 74 participants (actual)
- Lead sponsor
- University Hospital, MontpellierUniversity, hospital or other
- Study start
- 3 Jan 2014 (actual)
- Primary completion
- Dec 2016 (actual)
- Study completion
- 11 Apr 2017 (actual)
- First posted
- 29 Jan 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective multicenters randomized study to compare the efficiency and the socioeconomic impact of the endoscopic management (Overstitch technique) of weight regain after gastric bypass surgery to non invasive treatment
Detailed description
Nowadays morbid obesity (BMI ≥ 40kg/m²) is a major problem of public health in industrialized countries. About 500 000 patients would be affected by this disease in France in 2009. Prevalence of the morbid obesity raised from 0.3 % (± 0.1 %) of the population in 1997 to 1.1 % (± 0.1 %) in 2009 (Extrapolation of the data ObEpi on 2009 to the French population) (1). For this type of patient, the only long-term effective treatment recognized by the scientists is the bariatric surgery. (2-4) Roux and Y Gastric Bypass (GBP) is a consensual procedure, that has been described in the sixties, in this indication (approximately 11000 GBP performed in FRance in 2012 (5,6). This operation consists on the creation of a proximal gastric pouch (50 cc). A Roux and Y intestinal loop will be added to create a malabsorptive part. 60 to 80 % of excess weight loss described in the literature in the long-terms. Furthermore, improvement or remission of T2DM, sleep apnea syndrome, arterial hyperpressure, dyslipidemia) are emphasized in many trials (5, 7). However 15 to 20 % of the handled patients present a weight regain 5 years post surgery potentially explained by the dilation of the gastric pouch or the gastro jejunal anastomosis and thus a decrease of the restrictive effect. (8-11) To palliate this complication two solutions are described. (12-15; 19) The first one consists in a recalibration of the gastric poouch by surgical approachy. In this case, a ring of silicone or polypropylene can be positioned around the gastric pocket. Other possible solution is to redo a new gastrojejunostomy with a smaller size, by surgical access (laparotomy or laparoscopy). These interventions are very delicate because of important peritoneal adhesions and present a rate of significant morbidity especially if they are performed under laparotomy. The pure medical care does not allow long-term results stable. ²² A therapeutic dead end is reported often for this type of patient. A new possibility was recently described. (17-18) A recalibration can be realized by sutures performed under endoscopic approach at the level of the gastro jejunal anastomosis or from the gastric pouch by the APOLLO Endosurgery OverStitch. The digestive surgery by endoscopic way is rapidly expanding. The first results seem to be promising (resumed the weight loss) but owe to be estimated in a randomized study comparing this new process with the medical conventional treatment. A single-blind, randomized, forward-looking study, multicenter, comparative between two parallel groups of patients presenting a weight regain after GBP was thus organized. The main objective is to estimate the efficiency of the APOLLO Endosurgery OverStitch technique versus the non-interventional strategy. The secondary endpoints is to study the morbidity of the procedure, the evolution of quality of life of the patients, the medical economic impact of the innovation in 24 months.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Arm with Apollo Endosurgery OverStitch technical | Active comparator | Device: Regular endoscopy + endogastric suturing |
| Arm without Apollo Endosurgery OverStitch technical | Placebo comparator | Diagnostic Test: Regular endoscopy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Age > 18 years
- Surgical criteria: patient with bariatric surgery by gastric bypass since, at least, 24 months
- Clinics criteria of weight regain or treatment failure:
- Loss of early satiety (interrogation)
- Patient with a compatible psychological and cognitive status with the study,
Key exclusion criteria (4 listed)
- Pregnancy (plasma assay of beta-HCG positive)
- Presence of cardiovascular, neurological, psychiatric, endocrine, renal, gastrointestinal or tumor comorbidities making irrelevant patient participation in the judgment of the investigator
- Patient participating in another clinical study or participated in another study within the last 30 days or for which the annual compensation received exceeds € 4,500
- Patient with a contre-indication to the achievement of surgery (fistula, ulceration, ...)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Regular endoscopy + endogastric suturingPatients will get the usual endoscopy used for diagnosis. In addition, they will receive an endoscopic surgery using the APOLLO Endosuregery technique. The Apollo Endosurgery OverStitch is an endoscopic equipment which involves the suturing by endogastric way to decrease the size of the anastomosis gastrojujenal or gastric pouch | Device | Arm with Apollo Endosurgery OverStitch technical |
| Regular endoscopyPatients will get the usual endoscopy used for diagnosis. | Diagnostic test | Arm without Apollo Endosurgery OverStitch technical |
Primary outcome
Weight loss assessment of Apollo Endosurgery OverStitch technical
Time frame: At 12 and 24 months after surgery
The main objective is to compare the efficacy of endoscopic surgery Apollo Endosurgery OverStitch technical than the conventional non-interventional strategy in patients with weight regain after gastric bypass.Moreover, all of these patients will also benefit from the medical-nutritional usual care.
4 secondary outcomes
Comparison of both strategies on tolerance (adverse events and serious adverse events)
Time frame: At 12 months after Baseline and at each visit
Comparison of both strategies on comorbidities
Time frame: At 12 months after Baseline and at each visit
Comparison of both strategies on quality of life
Time frame: At 12 months after Baseline and at each visit
Comparison of both strategies on medico-economic impact (drugs fees, medical consultation fees..)
Time frame: At 12 months after Baseline and at each visit
Results and safety
The study was stopped early (reason given: Following the occurrence of four serious adverse events in the APOLLO group and after discussion with the investigator, we consider that this minimally invasive protocol causes an increased risk of morbidity and mortality.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Oct 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
7 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Regular endoscopy + endogastric suturing and Regular endoscopy in people with the Management of Weight Regain After Gastric Bypass by Endoscopic Suturing, run by University Hospital, Montpellier at 7 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Following the occurrence of four serious adverse events in the APOLLO group and after discussion with the investigator, we consider that this minimally invasive protocol causes an increased risk of morbidity and mortality.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight loss assessment of Apollo Endosurgery OverStitch technical (time frame: At 12 and 24 months after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025; AzTrials last refreshed its copy on 8 Nov 2026.